Patient Advocacy Council Mobile, AL - 36606

Patient Advocacy Council is categorized under Commercial Medical Research in Mobile, AL and active since 1999.

Patient Advocacy Council was established in 1999, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 4411100 by the NAICS.

If you are seeking more information, feel free to contact Lori A Nesbitt at the company’s single location by writing to 601 Bel Air Boulevard, Mobile, Alabama AL 36606 or by phoning (251) 479-5472. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Patient Advocacy Council
Contact Person: Lori A Nesbitt
Address: 601 Bel Air Boulevard, Mobile, Alabama 36606
Phone Number: (251) 479-5472
Website Address: pacirb.com
Annual Revenue (USD): $2.500.000 to $4.999.999
Founded: 1999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Medical Research
SIC Code: 8731
NAICS Code: 4411100
Share This Business:

Patient Advocacy Council was started in 1999 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 4411100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.

Feel free to contact Lori A Nesbitt for inquiries that concern Patient Advocacy Council by calling the company number (251) 479-5472, as your correspondence is most welcome. Additionally, the physical location of the single location of Patient Advocacy Council can be found at the coordinates 30.670022,-88.117894 as well as the street address 601 Bel Air Boulevard in Mobile, Alabama 36606.

For its online presence, you may visit Patient Advocacy Council’s website at pacirb.com and engage with its social media outlets through on Twitter and on Facebook.